Electrochemical Assessment of CYP3A4 Catalytic Activity in Bactosomes

被引:0
|
作者
Koroleva, Polina I. [1 ,2 ]
Kuzikov, Alexey V. [1 ,2 ]
Gilep, Andrei A. [1 ]
Bulko, Tatiana V. [1 ]
Shumyantseva, Victoria V. [1 ,2 ]
机构
[1] Inst Biomed Chem, Pogodinskaya St 10, Moscow 119121, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
Electrochemical analysis; Screen-printed electrodes; Voltammetry; Bioreactor; Electron transfer; Enzymatic assay; LIVER MICROSOMAL BIOREACTOR; DRIVEN DRUG-METABOLISM; CYTOCHROME-P450; 3A4; DICLOFENAC; FILM; BIOCATALYSIS; ACTIVATION; EFFICIENCY; REDUCTASE; KINETICS;
D O I
10.1007/s12668-024-01539-1
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
In this work, we present investigation on the behavior of bactosomes containing human cytochrome CYP3A4 in comparison with recombinant enzyme. The bactosomes were adsorbed on the surface of screen-printed electrodes modified with didodecyldimethylammonium bromide. We have shown that bactosomes are effective bioreactors in the case of drug metabolic electroenzymatic reactions. The electrocatalytic reaction was conducted at a working potential of - 0.50 divided by - 0.55 V. Drug conversion was registered by means of measuring of formaldehyde as product of N-demethylation reaction of erythromycin and time-dependent electrochemical oxidation of diclofenac during electrolysis at controlled working potential. The efficiencies of electrocatalysis of erythromycin N-demethylation as well-known cytochrome P450 3A4 substrate in the case of bactosomes containing human cytochrome P450 3A4 was 3.5 +/- 0.4 times higher in comparison with highly purified cytochrome P450 3A4-electrode as catalyst. The efficiencies of electrocatalysis of diclofenac 5-hydroxylation in the case of bactosomes were 3.1 +/- 0.3 times higher than for purified enzyme. Bactosomes are effective electrochemical enzymatic nanobioreactors with a high electroenzymatic efficiency for metabolite production.
引用
收藏
页码:2930 / 2939
页数:10
相关论文
共 50 条
  • [31] 4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
    Diczfalusy, Ulf
    Nylen, Hanna
    Elander, Pontus
    Bertilsson, Leif
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 183 - 189
  • [32] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
  • [33] Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment
    Dorne, JLCM
    Walton, K
    Renwick, AG
    FOOD AND CHEMICAL TOXICOLOGY, 2003, 41 (02) : 201 - 224
  • [34] BISPHENOL A INHIBITS HUMAN CYP3A4 ENZYME ACTIVITY IN VITRO
    Kuzbari, O.
    Lamb, J. G.
    Franklin, M. R.
    Hathaway, L. B.
    Johnstone, E. B.
    Peterson, C. M.
    FERTILITY AND STERILITY, 2011, 96 (03) : S157 - S158
  • [35] BISPHENOL A ALTERS HUMAN CYP3A4 ENZYME EXPRESSION AND ACTIVITY
    Kuzbari, O.
    Lamb, J. G.
    Hathaway, L. B.
    Franklin, M. R.
    Hammoud, A.
    Peterson, C. M.
    FERTILITY AND STERILITY, 2011, 96 (03) : S157 - S157
  • [36] Effect of danshen extract on the activity of CYP3A4 in healthy volunteers
    Qiu, Furong
    Wang, Guangji
    Zhang, Rong
    Sun, Jianguo
    Jiang, Jian
    Ma, Yueming
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (06) : 656 - 662
  • [37] Variability in activity of hepatic CYP3A4 in patients infected with HIV
    Slain, D
    Pakyz, A
    Israel, DS
    Monroe, S
    Polk, RE
    PHARMACOTHERAPY, 2000, 20 (08): : 898 - 907
  • [38] CYP3A4*1G regulates CYP3A4 intron 10 enhancer and promoter activity in an allelic-dependent manner
    Yang, Weihong
    Zhao, Dengzhi
    Han, Shengna
    Tian, Zengyuan
    Yan, Liang
    Zhao, Guodiang
    Kan, Quancheng
    Zhang, Wei
    Zhang, Lirong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (08) : 647 - 657
  • [39] Inhibitory Effects of Juices Prepared from Individual Vegetables on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells
    Tsujimoto, Masayuki
    Agawa, Chie
    Ueda, Shinya
    Yamane, Takayoshi
    Kitayama, Haruna
    Terao, Aya
    Fukuda, Tomoya
    Minegaki, Tetsuya
    Nishiguchi, Kohshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (09) : 1561 - 1565
  • [40] Kinetic study of CYP3A4 activity on verapamil by capillary electrophoresis
    Zhang, J
    Ha, PTT
    Lou, YJ
    Hoogmartens, J
    Van Schepdael, A
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) : 612 - 617